NEKTAR THERAPEUTICS COM STK USD0.0001NEKTAR THERAPEUTICS COM STK USD0.0001NEKTAR THERAPEUTICS COM STK USD0.0001

NEKTAR THERAPEUTICS COM STK USD0.0001

No trades
See on Supercharts
Market capitalization
‪260.74 M‬USD
−1.456USD
‪−276.06 M‬USD
‪90.12 M‬USD
‪177.94 M‬
Beta (1Y)
1.02

About NEKTAR THERAPEUTICS COM STK USD0.0001

CEO
Howard W. Robin
Headquarters
San Francisco
Website
Employees (FY)
137
Founded
1990
FIGI
BBG00LG7G039
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0UNL is 1.400 USD — it has increased by 0.01% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NEKTAR THERAPEUTICS COM STK USD0.0001 stocks are traded under the ticker 0UNL.
NEKTAR THERAPEUTICS COM STK USD0.0001 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0UNL stock is 3.62% volatile and has beta coefficient of 1.02. Check out the list of the most volatile stocks — is NEKTAR THERAPEUTICS COM STK USD0.0001 there?
0UNL earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.20 USD resulting in a −21.02% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about NEKTAR THERAPEUTICS COM STK USD0.0001 earnings.
NEKTAR THERAPEUTICS COM STK USD0.0001 revenue for the last quarter amounts to ‪24.14 M‬ USD despite the estimated figure of ‪21.26 M‬ USD. In the next quarter revenue is expected to reach ‪21.43 M‬ USD.
Yes, you can track NEKTAR THERAPEUTICS COM STK USD0.0001 financials in yearly and quarterly reports right on TradingView.
0UNL stock has fallen by 5.41% compared to the previous week, the month change is a 52.17% rise, over the last year NEKTAR THERAPEUTICS COM STK USD0.0001 has showed a 78.34% increase.
0UNL net income for the last quarter is ‪−42.08 M‬ USD, while the quarter before that showed ‪−45.84 M‬ USD of net income which accounts for 8.20% change. Track more NEKTAR THERAPEUTICS COM STK USD0.0001 financial stats to get the full picture.
Today NEKTAR THERAPEUTICS COM STK USD0.0001 has the market capitalization of ‪260.74 M‬, it has decreased by 8.72% over the last week.
No, 0UNL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0UNL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEKTAR THERAPEUTICS COM STK USD0.0001 stock right from TradingView charts — choose your broker and connect to your account.
0UNL reached its all-time high on Sep 5, 2018 with the price of 68.490 USD, and its all-time low was 0.435 USD and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 137.00 employees. See our rating of the largest employees — is NEKTAR THERAPEUTICS COM STK USD0.0001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEKTAR THERAPEUTICS COM STK USD0.0001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEKTAR THERAPEUTICS COM STK USD0.0001 stock shows the neutral signal. See more of NEKTAR THERAPEUTICS COM STK USD0.0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NEKTAR THERAPEUTICS COM STK USD0.0001 future price: according to them, 0UNL price has a max estimate of 5.00 USD and a min estimate of 1.00 USD. Read a more detailed NEKTAR THERAPEUTICS COM STK USD0.0001 forecast: see what analysts think of NEKTAR THERAPEUTICS COM STK USD0.0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEKTAR THERAPEUTICS COM STK USD0.0001 EBITDA is ‪−127.41 M‬ USD, and current EBITDA margin is −143.82%. See more stats in NEKTAR THERAPEUTICS COM STK USD0.0001 financial statements.